Advair Diskus 500/50mcg (red) 60s

Manufacturer GLAXO SMITH KLINE Active Ingredient Fluticasone and Salmeterol Inhalation Powder(floo TIK a sone & sal ME te role) Pronunciation AD-vair DIS-kus (floo TIK a sone & sal ME te role)
It is used to treat asthma.Some brands are used to treat COPD (chronic obstructive pulmonary disease).It may be given to you for other reasons. Talk with the doctor.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
đŸˇī¸
Drug Class
Antiasthmatic, Bronchodilator, Corticosteroid
đŸ§Ŧ
Pharmacologic Class
Inhaled Corticosteroid (ICS) and Long-Acting Beta2-Adrenergic Agonist (LABA) Combination
🤰
Pregnancy Category
Category C
✅
FDA Approved
Aug 2000
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Advair Diskus is an inhaler that contains two medicines: a corticosteroid (fluticasone) to reduce inflammation in your lungs, and a long-acting bronchodilator (salmeterol) to open up your airways. It's used once a day to help you breathe better and prevent flare-ups if you have COPD. It is not for sudden breathing problems.
📋

How to Use This Medicine

Proper Use of Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only.

Using Your Inhaler

Use your inhaler at the same time every day, as directed by your doctor or healthcare provider, even if you feel well.
Rinse your mouth with water after each use, but do not swallow the water. Instead, spit it out.
If you are using multiple inhaled medications, ask your doctor which one to use first.

Important Inhaler Handling Instructions

Only prepare a dose when you are ready to take it. If you prepare a dose and close the inhaler without taking it, the medication will be wasted and the inhaler may be damaged.
Do not breathe out into the inhaler.
After using your dose, close the inhaler.
Do not take an extra dose, even if you did not taste or feel the powder.

Maintenance and Cleaning

Do not take the inhaler device apart or wash it.
Do not use the inhaler with a spacer.
Do not breathe out into the device.
Clean the mouthpiece by wiping it with a dry tissue or cloth. Avoid washing or submerging it in water.

Tracking Your Doses

The inhaler has a built-in dose counter to track the number of doses remaining.
Dispose of the inhaler when the dose counter reaches "0," one month after opening the foil pouch, or after the expiration date, whichever occurs first.

Storage and Disposal

Store the medication at room temperature in a dry place, avoiding bathrooms.
Keep the inhaler in its foil pouch until you are ready to use it.

Missed Dose Instructions

If you miss a dose, skip it and return to your regular schedule.
* Do not take two doses at the same time or take extra doses.
💡

Lifestyle & Tips

  • Use regularly as prescribed, even if you feel better.
  • Do not use for sudden breathing problems; always carry a rescue inhaler (e.g., albuterol).
  • Rinse your mouth with water and spit it out after each dose to prevent oral thrush (yeast infection).
  • Do not exceed the prescribed dose or use more often than once daily.
  • Avoid smoking, as it can worsen COPD and reduce medication effectiveness.
  • Maintain good hydration and nutrition.
  • Get regular exercise as tolerated.
  • Follow up with your doctor regularly for lung function tests and overall health assessment.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: One inhalation (500 mcg fluticasone propionate and 50 mcg salmeterol) orally once daily
Dose Range: 500 - 50 mg

Condition-Specific Dosing:

COPD: One inhalation (500/50 mcg) once daily. Not for acute bronchospasm.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for 500/50mcg strength. Lower strengths (100/50, 250/50) are approved for asthma in children 4 years and older.
Adolescent: Not established for 500/50mcg strength. Lower strengths (100/50, 250/50) are approved for asthma in adolescents 12 years and older.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary
Moderate: No dosage adjustment necessary
Severe: No dosage adjustment necessary
Dialysis: No specific recommendations; use with caution due to potential for increased systemic exposure.

Hepatic Impairment:

Mild: No dosage adjustment necessary
Moderate: Use with caution; consider monitoring for systemic corticosteroid effects.
Severe: Use with caution; consider monitoring for systemic corticosteroid effects due to potential for increased systemic exposure.
Confidence: Medium

Pharmacology

đŸ”Ŧ

Mechanism of Action

Fluticasone propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It reduces inflammation in the airways, decreasing bronchial hyperreactivity and improving lung function. Salmeterol xinafoate is a long-acting beta2-adrenergic agonist (LABA) that selectively stimulates beta2-adrenergic receptors in the lungs, leading to relaxation of bronchial smooth muscle and bronchodilation. The combination provides both anti-inflammatory and bronchodilator effects.
📊

Pharmacokinetics

Absorption:

Bioavailability: Fluticasone: ~1% (oral), ~30% (inhaled systemic). Salmeterol: ~5% (inhaled systemic).
Tmax: Fluticasone: 0.5-1 hour. Salmeterol: 5-10 minutes.
FoodEffect: Not applicable for inhaled powder.

Distribution:

Vd: Fluticasone: ~318 L. Salmeterol: ~156 L.
ProteinBinding: Fluticasone: >90%. Salmeterol: ~96%.
CnssPenetration: Limited

Elimination:

HalfLife: Fluticasone: ~8 hours (terminal). Salmeterol: ~5.5 hours (terminal).
Clearance: Fluticasone: ~1150 mL/min. Salmeterol: ~1200 mL/min.
ExcretionRoute: Feces (primary for both), Urine (minor for both)
Unchanged: Fluticasone: <5% (urine). Salmeterol: <1% (urine).
âąī¸

Pharmacodynamics

OnsetOfAction: Salmeterol: 10-20 minutes (significant bronchodilation). Fluticasone: Days to weeks for full anti-inflammatory effect.
PeakEffect: Salmeterol: 2-4 hours. Fluticasone: 1-2 weeks.
DurationOfAction: Salmeterol: 12 hours. Fluticasone: Sustained anti-inflammatory effect with daily dosing.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABA) such as salmeterol, one of the active ingredients in ADVAIR DISKUS, increase the risk of asthma-related death. Data from a large, randomized, placebo-controlled clinical trial in asthma showed that LABA increased the risk of asthma-related death. This finding with salmeterol is considered a class effect of LABA. The safety and effectiveness of ADVAIR DISKUS in patients with asthma have not been established. ADVAIR DISKUS is not indicated for the primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required. ADVAIR DISKUS should not be initiated in patients during rapidly deteriorating or potentially life-threatening episodes of COPD or asthma. ADVAIR DISKUS should not be used more often than recommended, at higher doses than recommended, or with other LABA-containing products.
âš ī¸

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of infection, including:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or changed sputum production
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Signs of high blood sugar, such as:
+ Confusion
+ Drowsiness
+ Increased thirst or hunger
+ Frequent urination
+ Flushing
+ Rapid breathing
+ Fruity-smelling breath
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ Abnormal heartbeat
Signs of a weak adrenal gland, such as:
+ Severe nausea or vomiting
+ Severe dizziness or fainting
+ Muscle weakness
+ Fatigue
+ Mood changes
+ Decreased appetite
+ Weight loss
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Fainting
+ Changes in vision
Chest pain or pressure
Abnormal or rapid heartbeat
Shakiness
Nervousness or excitability
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Burning, numbness, or tingling sensations
Choking
Voice changes
Seizures
Bone pain
Sleep disturbances
Fatigue or weakness
Vaginal itching or discharge
Weight gain
Mouth irritation or sores
Redness or white patches in the mouth or throat

Breathing Problems: A Life-Threatening Condition

This medication can cause severe breathing problems, which may be life-threatening. If you experience trouble breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.

Other Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. If you notice any of the following side effects or any other symptoms that bother you or don't go away, contact your doctor:

Headache
Nausea or vomiting
Throat irritation
* Common cold symptoms

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening shortness of breath or wheezing
  • Increased need for your rescue inhaler
  • Chest pain or fast/irregular heartbeat
  • Severe dizziness or fainting
  • Signs of infection (fever, chills, increased cough or sputum color change)
  • White patches in your mouth or throat (oral thrush)
  • Blurred vision or eye pain
  • Unexplained weight gain, swelling, or muscle weakness (signs of systemic corticosteroid effects)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced.
If you are currently taking a similar medication. If you are unsure, consult your doctor or pharmacist for clarification.
Any prescription or over-the-counter medications, natural products, or vitamins you are taking that may interact with this medication. Certain medications used to treat HIV, infections, depression, and other conditions should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
If you have a milk allergy.

Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to discuss all of your medications (prescription and over-the-counter), natural products, vitamins, and health conditions with your doctor and pharmacist. They will help you determine if it is safe to take this medication with your existing regimen.

Remember, do not start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

When taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using this drug.

Effectiveness and Monitoring

It may take approximately 1 week to experience the full effect of this medication. If you have diabetes (high blood sugar), consult your doctor, as this drug may increase blood sugar levels. Immediately contact your doctor if your breathing problems worsen, your rescue inhaler is less effective, or you need to use it more frequently.

Dosage and Administration

Do not exceed the recommended dose or use this medication more often than prescribed. Overdose can be fatal, so it is crucial to follow your doctor's instructions. Discuss any concerns with your doctor.

Transitioning from Oral Steroids

When switching from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of symptoms such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar. If you experience any of these symptoms, contact your doctor immediately.

Stressful Situations

In cases of severe injury, surgery, or infection, you may require additional oral steroid doses to help your body cope with stress. Carry a warning card indicating that you may need extra steroids in these situations.

Long-term Use and Potential Risks

Prolonged use of this medication may increase the risk of developing cataracts or glaucoma. Consult your doctor and schedule regular eye exams as recommended.

Additionally, long-term use may cause osteoporosis (weak bones). Discuss your risk factors with your doctor and undergo bone density tests as advised.

Infection Risk

You may be more susceptible to infections while taking this medication. To minimize this risk, practice good hygiene by washing your hands frequently and avoiding close contact with people who have infections, colds, or flu.

Viral Infections

If you have not had chickenpox or measles before, avoid exposure to these viruses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed to chickenpox or measles, consult your doctor immediately.

Special Considerations

If you are 65 or older, use this medication with caution, as you may be more prone to side effects.

In children and teenagers, this medication may affect growth in some cases. Regular growth checks may be necessary, so consult your doctor.

Pregnancy and Breastfeeding

If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks of this medication with your doctor.

COPD Considerations

If you have Chronic Obstructive Pulmonary Disease (COPD), you are at a higher risk of developing pneumonia. This medication may further increase this risk, so consult your doctor to discuss the potential risks and benefits.
🆘

Overdose Information

Overdose Symptoms:

  • Chest pain
  • Fast or irregular heartbeat (tachycardia, arrhythmias)
  • Tremor
  • Nervousness
  • Headache
  • Dizziness
  • Nausea
  • Vomiting
  • Hypokalemia (low potassium)
  • Hyperglycemia (high blood sugar)
  • Seizures
  • Prolonged systemic corticosteroid effects (e.g., Cushingoid features, adrenal suppression) with chronic overdose.

What to Do:

Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment is supportive and symptomatic. Monitor cardiac status (ECG), serum potassium, and blood glucose. Consider cardioselective beta-blockers for severe cardiovascular effects, but use with extreme caution due to potential for bronchospasm.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin) - concomitant use may increase systemic exposure to fluticasone and salmeterol, leading to increased risk of Cushing's syndrome, adrenal suppression, and cardiovascular effects.
🔴

Major Interactions

  • Beta-blockers (non-cardioselective): May block the bronchodilatory effect of salmeterol and cause severe bronchospasm, especially in patients with asthma. Use with caution, and only if no suitable alternatives.
  • Diuretics (thiazide or loop): May potentiate hypokalemia and/or ECG changes associated with beta-agonists.
  • Tricyclic antidepressants (TCAs) and Monoamine oxidase inhibitors (MAOIs): May potentiate the cardiovascular effects of salmeterol. Administer with extreme caution, or not at all, to patients being treated with these agents or within 2 weeks of discontinuation.
🟡

Moderate Interactions

  • Other sympathomimetics: May potentiate adverse cardiovascular effects.
  • QTc-prolonging drugs: Increased risk of ventricular arrhythmias with salmeterol.
  • Other inhaled corticosteroids: Increased risk of systemic corticosteroid effects.
  • Other LABAs: Do not use with other LABA-containing products.
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Pulmonary Function Tests (FEV1)

Rationale: To establish baseline lung function and assess disease severity.

Timing: Prior to initiation of therapy.

Medical History (including cardiovascular, ocular, bone density)

Rationale: To identify pre-existing conditions that may be exacerbated or require monitoring.

Timing: Prior to initiation of therapy.

Oral examination

Rationale: To check for signs of oral candidiasis.

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

Pulmonary Function Tests (FEV1)

Frequency: Periodically (e.g., every 3-6 months or as clinically indicated)

Target: Improvement from baseline, stabilization of lung function.

Action Threshold: Significant decline in FEV1 or lack of improvement may indicate inadequate control or need for re-evaluation.

Signs and symptoms of COPD/asthma control

Frequency: At each visit

Target: Reduced frequency of exacerbations, improved symptom scores (e.g., CAT score for COPD), reduced rescue inhaler use.

Action Threshold: Increased symptoms, increased rescue inhaler use, or exacerbations require re-evaluation of therapy.

Adverse effects (e.g., oral candidiasis, pneumonia, cardiovascular symptoms, hypokalemia, hyperglycemia, bone density changes, ocular effects)

Frequency: At each visit

Target: Absence or minimal adverse effects.

Action Threshold: Presence of significant adverse effects requires intervention (e.g., antifungal for candidiasis, dose adjustment, or discontinuation).

Growth in pediatric patients (if applicable for lower strengths)

Frequency: Periodically

Target: Normal growth velocity.

Action Threshold: Growth retardation may indicate systemic corticosteroid effects.

đŸ‘ī¸

Symptom Monitoring

  • Increased shortness of breath
  • Increased cough
  • Increased wheezing
  • Increased sputum production
  • Increased need for rescue inhaler (e.g., albuterol)
  • Chest pain or palpitations
  • Muscle cramps or weakness (hypokalemia)
  • Increased thirst or urination (hyperglycemia)
  • Blurred vision or eye pain (glaucoma/cataracts)
  • Oral white patches (candidiasis)

Special Patient Groups

🤰

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Poorly controlled asthma/COPD in pregnancy poses risks to both mother and fetus. Fluticasone is generally preferred among inhaled corticosteroids due to lower systemic absorption. Salmeterol data is limited but no clear evidence of harm.

Trimester-Specific Risks:

First Trimester: Limited data, but generally considered low risk for inhaled corticosteroids and LABAs at therapeutic doses.
Second Trimester: No specific increased risks identified beyond general pregnancy risks.
Third Trimester: No specific increased risks identified. Monitor for signs of labor inhibition (theoretical with LABAs) or neonatal hypoglycemia/tachycardia (rare with maternal LABA use).
🤱

Lactation

Fluticasone and salmeterol are minimally excreted into breast milk. Benefits of breastfeeding should be weighed against the potential risk of infant exposure. Generally considered compatible with breastfeeding due to low systemic absorption and low levels in milk.

Infant Risk: Low. Monitor for signs of adverse effects (e.g., irritability, poor feeding, growth suppression) in the infant, though unlikely with typical doses.
đŸ‘ļ

Pediatric Use

The 500/50mcg strength is not indicated for pediatric patients. Lower strengths (100/50, 250/50) are approved for asthma in children 4 years and older. Monitor growth velocity in pediatric patients receiving inhaled corticosteroids due to potential for growth suppression.

👴

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients. However, elderly patients may be more susceptible to cardiovascular adverse effects of LABAs and systemic corticosteroid effects. Use with caution in patients with co-morbidities common in the elderly (e.g., cardiovascular disease, osteoporosis, glaucoma, cataracts, diabetes).

Clinical Information

💎

Clinical Pearls

  • Advair Diskus 500/50mcg is specifically indicated for maintenance treatment of COPD, not for asthma in adults or children.
  • Emphasize the importance of daily, consistent use, even when symptoms are well-controlled.
  • Educate patients on the proper Diskus inhalation technique and the importance of rinsing the mouth after each dose to prevent oral candidiasis.
  • Stress that Advair is NOT a rescue inhaler and patients should always have a short-acting beta-agonist (SABA) available for acute symptoms.
  • Be aware of potential drug interactions, especially with strong CYP3A4 inhibitors, beta-blockers, and drugs that prolong the QTc interval.
  • Monitor for systemic corticosteroid effects (e.g., adrenal suppression, bone density loss, cataracts, glaucoma, hyperglycemia) with long-term use, especially at higher doses.
  • Patients should be advised not to stop therapy abruptly, as this can lead to adrenal insufficiency.
🔄

Alternative Therapies

  • Single-agent inhaled corticosteroids (e.g., fluticasone propionate, budesonide, mometasone)
  • Single-agent long-acting beta2-agonists (e.g., salmeterol, formoterol, indacaterol, olodaterol)
  • Long-acting muscarinic antagonists (LAMAs) (e.g., tiotropium, umeclidinium, glycopyrronium)
  • Phosphodiesterase-4 (PDE4) inhibitors (e.g., roflumilast - for severe COPD with chronic bronchitis)
  • Oral corticosteroids (for exacerbations or severe cases, not for maintenance)
  • Oxygen therapy (for severe hypoxemia)
💰

Cost & Coverage

Average Cost: $350 - $600 per 60-dose inhaler
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (preferred or non-preferred brand), Tier 1 (generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it occurred.